SCHEMBL6583643

SCHEMBL6583643

CCCNC(=O)[C](F)F

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6858080 0.85 MMP1 (0.52) —
SCHEMBL24359054 0.82 — —
SCHEMBL16478396 0.80 MMP1 (0.40) —
SCHEMBL17333520 0.80 — —
SCHEMBL14902293 0.79 MMP1 (0.39) —
SCHEMBL3414867 0.78 — —
SCHEMBL583601 0.78 — —
SCHEMBL6940482 0.78 MMP1 (0.46) —
SCHEMBL6850994 0.76 NPC1 (0.47) —
SCHEMBL25766357 0.76 MMP1 (0.44) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6835714-B1 Heterocyclic compounds, intermediates thereof and elastase inhibitors DAINIPPON PHARMACEUTICAL CO., LTD. (JP) 2004-12-28 — — US disclosed
EP-1157998-B1 HETEROCYCLIC COMPOUNDS, INTERMEDIATES THEREOF AND ELASTASE INHIBITORS DAINIPPON PHARMACEUTICAL CO (JP) 2004-02-11 — — EP disclosed
EP-1157998-A1 HETEROCYCLIC COMPOUNDS, INTERMEDIATES THEREOF AND ELASTASE INHIBITORS Dainippon Pharmaceutical Co., Ltd. (JP) 2001-11-28 — — EP disclosed
Send feedback